Affiliation:
1. Metabolic Solutions Development Company; Kalamazoo MI USA
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference52 articles.
1. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, Ciglitazone), a new antidiabetic agent;Fujita;Diabetes,1983
2. New oral thiazolidinedione antidiabetic agents act as insulin sensitizers;Hofmann;Diabetes Care,1992
3. Thiazolidinediones today;Bailey;Br J Diabetes Vasc Dis,2011
4. Thiazolidinediones: a pharmacological review;Owens;Clin Drug Invest,2002
5. Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity;Giannini;J Endocrinol Invest,2004
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献